Abstract
4-1BB is an inducible member of the TNFR family found on antigen-activated T cells as well as on cells of the innate immune system. 4-1BB is a late-acting survival factor for effector T cells, sustaining CD8 T cell survival in the lung during severe respiratory infection with influenza virus. With milder influenza infections, 4-1BBL is dispensable for initial CD8 T cell responses. However, 4-1BB on the CD8 T cells and 4-1BBL primarily on radioresistant cells are important in maintaining CD8 T cell memory to influenza virus. 4-1BB is induced on memory but not naive CD8 T cells independently of antigen, by common gamma chain cytokines such as IL-15 and IL-2. This allows memory CD8 T cells to respond to 4-1BBL in the absence of antigen. 4-1BB transduces signals via recruitment of TRAF1 and TRAF2. Earlier work had shown that TRAF2 was essential for 4-1BB signaling in T cells, whereas the role of TRAF1 was unclear. Our recent studies have demonstrated the importance of TRAF1 in the survival of activated and memory CD8 T cells. We also showed that 4-1BB and TRAF1 are important in the costimulation-dependent rescue of functional CD8 T cells from a starting population of non-functional HIV-specific T cells isolated from chronically infected individuals. Downstream of 4-1BB, TRAF1 maintains the stability of TRAF2 and allows ERK-dependent depletion of the proapoptotic molecule BIM, resulting in increased CD8 T survival. Recently several reports have identified linkages between autoimmunity and single nucleotide polymorphisms in the TRAF1/C5 region. Further work is required to determine whether specific polymorphisms in TRAF1 could influence the ability of different individuals to respond to infection.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Bertram EM, Dawicki W, Watts TH (2004) Role of T cell costimulation in anti-viral immunity. Sem Immunol 16:185–196
Sabbagh L, Snell LM, Watts TH (2007) TNF family ligands define niches for T cell memory. Trends Immunol 28:333–339
Watts TH (2005) TNF/TNFR family members in costimulation of T cell responses. Ann Rev Immunol 23:23–68
Lynch DH (2008) The promise of 4-1BB (CD137)-mediated immunomodulation and the immunotherapy of cancer. Immunol Rev 222:277–286
Melero I, Murillo O, Dubrot J, Hervas-Stubbs S, Perez-Gracia JL (2008) Multi-layered action mechanisms of CD137 (4-1BB)-targeted immunotherapies. Trends Pharmacol Sci 29:383–390
Wang C, Lin GH, McPherson AJ, Watts TH (2009) Immune regulation by 4-1BB and 4-1BBL: complexities and challenges. Immunol Rev 229:192–215
Saoulli K, Lee SY, Cannons JL, Yeh WC, Santana A, Goldstein MD, Bangia N, DeBenedette MA, Mak TW, Choi Y, Watts TH (1998) CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand. J Exp Med 187:1849–1862
Jang IK, Lee ZH, Kim YJ, Kim SH, Kwon BS (1998) Human 4-1BB (CD137) signals are mediated by TRAF2 and activate nuclear factor-kappa B. Bioch Biophys Res Comm 242:613–620
Arch RH, Thompson CB (1998) 4-1BB and Ox40 are members of a tumor necrosis factor (TNF)-nerve growth factor receptor subfamily that bind TNF receptor-associated factors and activate nuclear factor κB. Mol Cell Biol 18:558–565
Cannons JL, Choi Y, Watts TH (2000) Role of TNF receptor-associated factor 2 and p38 mitogen-activated protein kinase activation during 4-1BB-dependent immune response. J Immunol 165:6193–6204
Rothe M, Wong SC, Henzel WJ, Goeddel DV (1994) A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 78:681–692
Carpentier I, Beyaert R (1999) TRAF1 is a TNF inducible regulator of NF-kappaB activation. FEBS Lett 460:246–250
Tsitsikov EN, Laouini D, Dunn IF, Sannikova TY, Davidson L, Alt FW, Geha RS (2001) TRAF1 is a negative regulator of TNF signaling: enhanced TNF signaling in TRAF1-deficient mice. Immunity 15:647–657
Speiser DE, Lee SY, Wong B, Arron J, Santana A, Kong YY, Ohashi PS, Choi Y (1997) A regulatory role for TRAF1 in antigen-induced apoptosis of T cells. J Exp Med 185:1777–1783
Jameson SC, Carbone FR, Bevan MJ (1993) Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells. J Exp Med 177:1541–1550
Shuford WW, Klussman K, Tritchler DD, Loo DT, Chalupny J, Siadak AW, Brown TJ, Emswiler J, Raecho H, Larsen CP, Pearson T C, Ledbetter JA, Aruffo A, Mittler RS (1997) 4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses. J Exp Med 186:47–55
Melero I, Shuford WW, Newby SA, Aruffo A, Ledbetter JA, Hellstrom KE, Mittler RS, Chen L (1997) Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors. Nature Med 3:682–685
Topham DJ, Castrucci MR, Wingo FS, Belz GT, Doherty PC (2001) The role of antigen in the localization of naive, acutely activated, and memory CD8(+) T cells to the lung during influenza pneumonia. J Immunol 167:6983–6990
Sabbagh L, Pulle G, Liu Y, Tsitsikov EN, Watts TH (2008) ERK-dependent Bim modulation downstream of the 4-1BB-TRAF1 signaling axis is a critical mediator of CD8 T cell survival in vivo. J Immunol 180:8093–8101
Sabbagh L, Srokowski CC, Pulle G, Snell LM, Sedgmen BJ, Liu Y, Tsitsikov EN, Watts TH (2006) A critical role for TNF receptor-associated factor 1 and Bim down-regulation in CD8 memory T cell survival. Proc Natl Acad Sci U S A 103:18703–18708
Bukczynski J, Wen T, Ellefsen K, Gauldie J, Watts TH (2004) Costimulatory ligand 4-1BBL (CD137L) as an efficient adjuvant for human antiviral cytotoxic T cell responses. Proc Natl Acad Sci U S A 101:1291–1296
Wang C, Wen T, Routy JP, Bernard NF, Sekaly RP, Watts TH (2007) 4-1BBL Induces TNF receptor-associated factor 1-dependent Bim modulation in human T cells and is a critical component in the costimulation-dependent rescue of functionally impaired HIV-specific CD8 T Cells. J Immunol 179:8252–8263
Akiba H, Nakano H, Nishinaka S, Shindo M, Kobata T, Atsuta M, Morimoto C, Ware CF, Malinin NL, Wallach D, Yagita H, Okumura K (1998) CD27, a member of the tumor necrosis factor receptor superfamily, activates NF-kappaB and stress-activated protein kinase/c-Jun N-terminal kinase via TRAF2, TRAF5, and NF-kappaB-inducing kinase. J Biol Chem 273:13353–13358
Shin H, Wherry EJ (2007) CD8 T cell dysfunction during chronic viral infection. Curr Opin Immunol 19:408–415
Trimble LA, Lieberman J (1998) Circulating CD8 T lymphocytes in human immunodeficiency virus-infected individuals have impaired function and downmodulate CD3 zeta, the signaling chain of the T-cell receptor complex. Blood 91:585–594
Appay V, Nixon DF, Donahoe SM, Gillespie GM, Dong T, King A, Ogg GS, Spiegel HM, Conlon C, Spina CA, Havlir DV, Richman DD, Waters A, Easterbrook P, McMichael AJ, Rowland-Jones SL (2000) HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function. J Exp Med 192:63–75
Migueles SA, Laborico AC, Shupert WL, Sabbaghian MS, Rabin R, Hallahan CW, Van Baarle D, Kostense S, Miedema F, McLaughlin M, Ehler L, Metcalf J, Liu S, Connors M (2002) HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat Immunol 3:1061–1068
Pantaleo G, Harari A (2006) Functional signatures in antiviral T-cell immunity for monitoring virus-associated diseases. Nat Rev Immunol 6:417–423
Pantaleo G, Koup RA (2004) Correlates of immune protection in HIV-1 infection: what we know, what we don’t know, what we should know. Nat Med 10:806–810
Bukczynski J, Wen T, Wang C, Christie N, Routy JP, Boulassel MR, Kovacs CM, Macdonald KS, Ostrowski M, Sekaly RP, Bernard NF, Watts TH (2005) Enhancement of HIV-specific CD8 T cell responses by dual costimulation with CD80 and CD137L. J Immunol 175:6378–6389
Plenge RM, Seielstad M, Padyukov L, Lee AT, Remmers EF, Ding B, Liew A, Khalili H, Chandrasekaran A, Davies LR, Li W, Tan AK, Bonnard C, Ong RT, Thalamuthu A, Pettersson S, Liu C, Tian C, Chen WV, Carulli JP, Beckman EM, Altshuler D, Alfredsson L, Criswell LA, Amos CI, Seldin MF, Kastner DL, Klareskog L, Gregersen PK (2007) TRAF1-C5 as a risk locus for rheumatoid arthritis--a genomewide study. N Engl J Med 357:1199–1209
Kurreeman FA, Padyukov L, Marques RB, Schrodi SJ, Seddighzadeh M, Stoeken-Rijsbergen G, van der Helm-van Mil AH, Allaart CF, Verduyn W, Houwing-Duistermaat J, Alfredsson L, Begovich AB, Klareskog L, Huizinga TW, Toes RE (2007) A candidate gene approach identifies the TRAF1/C5 region as a risk factor for rheumatoid arthritis. PLoS Med 4:e278
Albers HM, Kurreeman FA, Houwing-Duistermaat JJ, Brinkman DM, Kamphuis SS, Girschick HJ, Wouters C, Van Rossum MA, Verduijn W, Toes RE, Huizinga TW, Schilham MW, ten Cate R (2008) The TRAF1/C5 region is a risk factor for polyarthritis in juvenile idiopathic arthritis. Ann Rheum Dis 67:1578–1580
Behrens EM, Finkel TH, Bradfield JP, Kim CE, Linton L, Casalunovo T, Frackelton EC, Santa E, Otieno FG, Glessner JT, Chiavacci RM, Grant SF, Hakonarson H (2008) Association of the TRAF1-C5 locus on chromosome 9 with juvenile idiopathic arthritis. Arthritis Rheum 58:2206–2207
Kurreeman FA, Goulielmos GN, Alizadeh BZ, Rueda B, Houwing-Duistermaat J, Sanchez E, Bevova M, Radstake TR, Vonk MC, Galanakis E, Ortego N, Verduyn W, Zervou MI, Consortium S, Roep BO, Dema B, Espino L, Urcelay E, Boumpas DT, van den Berg LH, Wijmenga C, Koeleman BP, Huizinga TW, Toes RE, Martin J (2010) The TRAF1-C5 region on chromosome 9q33 is associated with multiple autoimmune diseases. Ann Rheum Dis 69:696–699
Panoulas VF, Smith JP, Nightingale P, Kitas GD (2009) Association of the TRAF1/C5 locus with increased mortality, particularly from malignancy or sepsis, in patients with rheumatoid arthritis. Arthritis Rheum 60:39–46
Zervou MI, Sidiropoulos P, Petraki E, Vazgiourakis V, Krasoudaki E, Raptopoulou A, Kritikos H, Choustoulaki E, Boumpas DT, Goulielmos GN (2008) Association of a TRAF1 and a STAT4 gene polymorphism with increased risk for rheumatoid arthritis in a genetically homogeneous population. Hum Immunol 69:567–571
Bertram EM, Lau P, Watts TH (2002) Temporal segregation of CD28 versus 4-1BBL-mediated costimulation: 4-1BBL influences T cell numbers late in the primary response and regulates the size of the memory response following influenza infection. J Immunol 168:3777–3785
Pulle G, Vidric M, Watts TH (2006) IL-15-dependent induction of 4-1BB promotes Ag-independent CD8 memory T cell survival. J Immunol 176:2739–2748
Lin GH, Sedgmen BJ, Moraes TJ, Snell LM, Topham DJ, Watts TH (2009) Endogenous 4-1BB ligand plays a critical role in protection from influenza-induced disease. J Immunol 182:934–947
Bertram EM, Dawicki W, Sedgmen B, Bramson JL, Lynch DH, Watts TH (2004) A switch in costimulation from CD28 to 4-1BB during primary versus secondary CD8 T cell response to influenza in vivo. J Immunol 172:981–988
Zhu Y, Zhu G, Luo L, Flies AS, Chen L (2007) CD137 stimulation delivers an antigen-independent growth signal for T lymphocytes with memory phenotype. Blood 109:4882–4889
Becker TC, Coley SM, Wherry EJ, Ahmed R (2005) Bone marrow is a preferred site for homeostatic proliferation of memory CD8 T cells. J Immunol 174:1269–1273
Burkett PR, Koka R, Chien M, Chai S, Boone DL, Ma A (2004) Coordinate expression and trans presentation of interleukin (IL)-15Ralpha and IL-15 supports natural killer cell and memory CD8+ T cell homeostasis. J Exp Med 200:825–834
Schluns KS, Lefrancois L (2003) Cytokine control of memory T-cell development and survival. Nat Rev Immunol 3:269–279
Zapata JM, Krajewska M, Krajewski S, Kitada S, Welsh K, Monks A, McCloskey N, Gordon J, Kipps TJ, Gascoyne RD, Shabaik A, Reed JC (2000) TNFR-associated factor family protein expression in normal tissues and lymphoid malignancies. J Immunol 165:5084–5096
Niu L, Strahotin S, Hewes B, Zhang B, Zhang Y, Archer D, Spencer T, Dillehay D, Kwon B, Chen L, Vella AT, Mittler RS (2007) Cytokine-mediated disruption of lymphocyte trafficking, hemopoiesis, and induction of lymphopenia, anemia, and thrombocytopenia in anti-CD137-treated mice. J Immunol 178:4194–4213
Acknowledgments
Funding for our research is provided by the Canadian Institutes of Health Research (CIHR) and the Canadian Cancer Society. G.H.Y. Lin is funded by a CIHR studentship; L.M. Snell is funded by the Fonds de la recherche en santé Quebec; C. Wang is funded by an Ontario HIV treatment network studentship; and L. Sabbagh, by a fellowship from the Leukemia and Lymphoma Society of America. T.H.W. holds the sanofi pasteur chair in Human Immunology at the University of Toronto.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this paper
Cite this paper
Watts, T.H., Lin, G.H., Wang, C., McPherson, A.J., Snell, L.M., Sabbagh, L. (2011). Role of 4-1BBL and TRAF1 in the CD8 T Cell Response to Influenza Virus and HIV. In: Wallach, D., Kovalenko, A., Feldmann, M. (eds) Advances in TNF Family Research. Advances in Experimental Medicine and Biology, vol 691. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-6612-4_19
Download citation
DOI: https://doi.org/10.1007/978-1-4419-6612-4_19
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-6611-7
Online ISBN: 978-1-4419-6612-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)